| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
82,110,000 |
| Market
Cap: |
3.51(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$31.73 - $53.69 |
|
| Level
I Sector: |
Consumer Discretionary |
| Level
II Sector: |
Leisure |
| Level
III Sector: |
Restaurants |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
NASDAQ INDUSTRIAL |
|
S&P SMALLCAP 600 |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Ultragenyx Pharmaceutical is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of products for the treatment of genetic diseases. Co. has four commercially approved products, Crysvita® (burosumab) for the treatment of X-linked hypophosphatemia and tumor-induced osteomalacia, Mepsevii® (vestronidase alfa) for the treatment of mucopolysaccharidosis VII, or Sly Syndrome, Dojolvi® (triheptanoin) for the treatment of long-chain fatty acid oxidation disorders, and Evkeeza® (evinacumab) for the treatment of homozygous familial hypercholesterolemia.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
69,133 |
99,133 |
200,384 |
249,340 |
| Total Sell Value |
$3,373,178 |
$4,809,278 |
$8,291,909 |
$10,478,837 |
| Total People Sold |
8 |
8 |
9 |
12 |
| Total Sell Transactions |
10 |
11 |
20 |
34 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Huizenga Theodore Alan |
SVP, Controller and PAO |
• – – |
2020-07-08 |
4 |
OE |
$21.00 |
$42,000 |
D/D |
2,000 |
18,582 |
|
- |
|
| Fust Matthew K |
Director |
– • – |
2020-07-06 |
4 |
AS |
$90.00 |
$556,290 |
D/D |
(6,181) |
13,550 |
|
35% |
|
| Fust Matthew K |
Director |
– • – |
2020-07-06 |
4 |
OE |
$21.00 |
$129,801 |
D/D |
6,181 |
19,731 |
|
- |
|
| Harris Erik |
EVP & Chief Commercial Officer |
• – – |
2020-07-06 |
4 |
D |
$86.75 |
$22,555 |
D/D |
(260) |
23,590 |
|
- |
|
| Huizenga Theodore Alan |
SVP, Controller and PAO |
• – – |
2020-07-01 |
4 |
AS |
$81.00 |
$211,491 |
D/D |
(2,611) |
17,220 |
|
43% |
|
| Huizenga Theodore Alan |
SVP, Controller and PAO |
• – – |
2020-07-01 |
4 |
OE |
$21.00 |
$31,500 |
D/D |
1,500 |
18,720 |
|
- |
|
| Fust Matthew K |
Director |
– • – |
2020-07-01 |
4 |
AS |
$85.00 |
$425,000 |
D/D |
(5,000) |
13,550 |
|
43% |
|
| Fust Matthew K |
Director |
– • – |
2020-07-01 |
4 |
OE |
$21.00 |
$105,000 |
D/D |
5,000 |
18,550 |
|
- |
|
| Parschauer Karah Herdman |
EVP and General Counsel |
• – – |
2020-06-20 |
4 |
D |
$78.22 |
$50,765 |
D/D |
(649) |
26,663 |
|
- |
|
| Harris Erik |
EVP & Chief Commercial Officer |
• – – |
2020-06-19 |
4 |
D |
$78.22 |
$23,701 |
D/D |
(303) |
23,850 |
|
- |
|
| Sharp Shalini |
CFO & Executive Vice President |
• – – |
2020-06-04 |
4 |
S |
$74.01 |
$189,762 |
D/D |
(2,564) |
101,208 |
|
-34% |
|
| Sharp Shalini |
CFO & Executive Vice President |
• – – |
2020-06-04 |
4 |
OE |
$48.43 |
$124,175 |
D/D |
2,564 |
103,772 |
|
- |
|
| Harris Erik |
EVP & Chief Commercial Officer |
• – – |
2020-06-03 |
4 |
S |
$74.69 |
$187,920 |
D/D |
(2,516) |
20,854 |
|
-28% |
|
| Sharp Shalini |
CFO & Executive Vice President |
• – – |
2020-06-03 |
4 |
S |
$74.23 |
$759,670 |
D/D |
(10,234) |
101,208 |
|
-28% |
|
| Sharp Shalini |
CFO & Executive Vice President |
• – – |
2020-06-03 |
4 |
OE |
$48.43 |
$495,633 |
D/D |
10,234 |
111,442 |
|
- |
|
| Pinion John Richard |
See Remarks |
• – – |
2020-06-01 |
4 |
D |
$69.38 |
$18,178 |
D/D |
(262) |
49,341 |
|
- |
|
| Sharp Shalini |
CFO & Executive Vice President |
• – – |
2020-06-01 |
4 |
D |
$69.38 |
$24,144 |
D/D |
(348) |
101,208 |
|
- |
|
| Huang Dennis Karl |
EVP & Chief Tech Ops Officer |
• – – |
2020-06-01 |
4 |
D |
$69.38 |
$18,178 |
D/D |
(262) |
34,961 |
|
- |
|
| Kassberg Thomas Richard |
CBO & EVP |
• – – |
2020-06-01 |
4 |
D |
$69.38 |
$24,144 |
D/D |
(348) |
101,740 |
|
- |
|
| Kakkis Emil D |
President & CEO |
• • – |
2020-06-01 |
4 |
D |
$69.38 |
$92,553 |
D/D |
(1,334) |
611,041 |
|
- |
|
| Huizenga Theodore Alan |
SVP, Controller and PAO |
• – – |
2020-05-26 |
4 |
AS |
$74.93 |
$19,482 |
D/D |
(260) |
18,331 |
|
21% |
|
| Huizenga Theodore Alan |
SVP, Controller and PAO |
• – – |
2020-05-25 |
4 |
D |
$73.81 |
$31,960 |
D/D |
(433) |
18,591 |
|
- |
|
| Sharp Shalini |
CFO & Executive Vice President |
• – – |
2020-05-19 |
4 |
S |
$73.32 |
$522,625 |
D/D |
(7,128) |
101,556 |
|
-28% |
|
| Sharp Shalini |
CFO & Executive Vice President |
• – – |
2020-05-19 |
4 |
OE |
$48.43 |
$431,710 |
D/D |
7,128 |
104,851 |
|
- |
|
| Aliski William |
Director |
– • – |
2020-05-18 |
4 |
S |
$74.02 |
$1,480,322 |
I/I |
(20,000) |
70,350 |
|
-29% |
|
628 Records found
|
|
Page 10 of 26 |
|
|
0.45 (1.04%) 
